Converting Enzyme Inhibitor Temocaprilat Prevents High Glucose-Mediated Suppression of Human Aortic Endothelial Cell Proliferation

Journal of Cardiovascular Pharmacology

Volumn 42, Issue SUPPL. 1, 2003, Pages

  Yasunari, Kenichi ^a   Maeda, Kensaku ^a   Watanabe, Takanori ^a   Nakamura, Munehiro ^a   Asada, Akira ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Oxidative stress; Protein kinase C

Indexed keywords

BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; CALPHOSTIN C; CARBOXYDICHLOROFLUORESCEIN DIACETATE BIS ACETOXYMETHYL ESTER; CHELERYTHRINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTER DERIVATIVE; GLUCOSE; ICATIBANT; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TEMOCAPRILAT; UNCLASSIFIED DRUG;

AORTA; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0345017154     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200312001-00013     Document Type: Conference Paper

References (21)

1. Graier WF, Simecek S, Kukovetz WR, Kostner GM. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 1996;45:1386-95.
2. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
3. Pieper GM, Dondlinger LA. Antioxidant pyrrolidine dithiocarbamate prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration. Diabetologia 1998;41:806-12.
4. Morrison AD, Clements RS Jr, Winegrad AI. Effect of elevated glucose concentrations on the metabolism of the aortic wall. J Clin Invest 1972;51:3114-23.
5. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
6. Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin cultured human endothelial cells. J Clin Invest 1991;87:1999-2004.
7. Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J. Mechanism of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ Res 1997;81:953-62.
8. Yasunari K, Kohno M, Kano H, Minami M, Yokokawa K, Yoshikawa J. Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation 1999;99:1370-8.
9. Yasunari K, Kohno M, Kano H, et al. Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary smooth muscle cells induced by high glucose. Hypertension 2000;35:1092-8.
10. Yasunari K, Maeda K, Minami M, Yoshikawa J. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress. Arterioscler Thromb Vasc Biol 2001;21:937-42.
11. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Pressure promotes angiotensin II-mediated migration of human coronary smooth muscle cells through increase in oxidative stress. Hypertension 2002;39(Pt 2):433-7.
12. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
13. Després J-P, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
14. Arakawa M, Sasaki M, Ohmori M, Harada K, Fujimura A. Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients. Eur J Clin Pharmacol 2001;56:775-9.
15. Kamal K, Du W, Mills I, Sumpio BE. Antiproliferative effect of elevated glucose in human microvascular endothelial cells. J Cell Biochem 1998;71:491-501.
16. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-45.
17. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001;88:E14-E22.
18. 2 kinin receptor within the plasma membrane of native endothelial cells. Circulation 1999;99:2034-40.
19. Squire IB, O'Kane KP, Anderson N, Reid JL. Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 2000;36:132-6.
20. Goligorsky MS, Chen J, Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 2001;37:744-8.
21. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 2003;278:12094-100.